# SecreTech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/secretech

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Latest round: Angel (Jan 19, 2024)
- Investors on record: 4

## About

Based in Shanghai, China, and founded in 2023, SecreTech operates as a biotechnology company that focuses on the development of novel biomarkers and cellular exosomes. In January 2024, the company closed an angel funding led by new investor Shanghai Healthcare Capital, with participation from other new investors Bio Venture, Sinan Yuanke, and Sino-Singapore Suzhou Industrial Park Industrial Investment.

SecreTech has developed an antibody affinity-based proteomic detection platform capable of analyzing low-abundance proteomes from plasma and other samples, which solves the current problems in proteomics research and development. Its proprietary Proximity Barcoding Assay (PBA) uses a unique combination of protein molecular tags and RCA neighborhood tags to identify a cluster of proteins. The services of the company can be used for protein co-localization, qualitative and quantitative analysis of proteins at the level of protein complexes, exosomes and cells.

## Funding rounds

- Angel, Jan 19, 2024 — YuanBio Venture, Shanghai Healthcare Capital, Sino-Singapore Suzhou Industrial Park Industrial Investment, Sinan Yuanke

## Investors

- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Angel
- Shanghai Healthcare Capital (https://capitalatlas.ai/funds/shanghai-healthcare-capital) — Angel
- Sino-Singapore Suzhou Industrial Park Industrial Investment — Angel
- Sinan Yuanke (https://capitalatlas.ai/funds/sinan-yuanke) — Angel